While, the mechanism by which IGPR-1 regulates phosphorylation of histone H2AX needs further investigation, the present data demonstrate that IGPR-1 by modulating phosphorylation of histone H2AX acts to reduce the sensitivity of tumor cells toward the DNA-damaging agent, doxorubicin. This evidence concerns the gene H2AX and neoplasm.